4//SEC Filing
BioPharmX Corp 4
Accession 0001424422-17-000005
CIK 0001504167operating
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 5:46 PM ET
Size
5.6 KB
Accession
0001424422-17-000005
Insider Transaction Report
Form 4
BioPharmX Corpbpmx
Morlock Stephen
Director
Transactions
- Award
Option to purchase common stock
2017-04-18$0.74/sh+200,000$148,000→ 200,000 total(indirect: By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03)Exercise: $0.74From: 2017-05-18Exp: 2027-04-18→ Common stock (200,000 underlying)
Footnotes (2)
- [F1]This option vests ratably over 12 months with the first vesting starting on 5/18/17.
- [F2]Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03
Documents
Issuer
BioPharmX Corp
CIK 0001504167
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001504167
Filing Metadata
- Form type
- 4
- Filed
- Apr 18, 8:00 PM ET
- Accepted
- Apr 19, 5:46 PM ET
- Size
- 5.6 KB